EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Evaluating the correlation between pretreatment 18F-FDG PET/CT metabolic parameters and tumor-infiltrating lymphocyte levels in nonluminal breast cancer and impact on survival

Muge Tamam, Halim Ozcevik, Gamze Kulduk, Merve Nur Acar Tayyar, Gunduzalp Bugrahan Babacan

Pathology and Oncology Research · 08.01.2025 · 30

DOI: 10.3389/pore.2024.1612014 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Pathology and Oncology Research, online erschienen am 08.01.2025. Verfasst von Muge Tamam und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Nuclear Medicine, Prof. Dr. Cemil Taşcıoğlu City Hospital, University of Health Sciences, Istanbul, Türkiye. Hauptthemen laut MEDLINE: Fluorodeoxyglucose F18, Breast Neoplasms, Positron Emission Tomography Computed Tomography, Lymphocytes, Tumor-Infiltrating. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 28 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background and Objectives This study aims to evaluate the correlation between Tumor-Infiltrating Lymphocyte (TIL) levels and Fluorine-18 fluorodeoxyglucose ( 18 F-FDG) metabolic parameters, including spleen and bone marrow FDG uptake and tumor heterogeneity in non-luminal breast cancers (NLBC), and to elucidate their association with survival outcomes.

Methods

We retrospectively analyzed data from 100 females with stage 2–4 NLBC who underwent pretreatment 18 F-FDG Positron emission tomography-computed tomography (PET/CT). TIL was scored based on Hematoxylin-Eosin-stained specimens and 18 F-FDG PET metabolic parameters, including maximum standardized uptake value (SUVmax), mean standardized uptake value (SUVmean), metabolic tumor volume (MTV), total lesion glycolysis (TLG), liver, spleen, and bone marrow FDG uptake were calculated. Heterogeneity Index (HI)1, HI2, and HI3 indices were analyzed with FDG metabolic parameters. The association between these factors and overall survival was analyzed using multivariate Cox regression models.

Results

TIL showed weak negative correlations with tumor size, tumor (T), and metastasis (M) stages. No significant correlation was found between TIL levels and overall SUV values. However, in stage 4, TIL correlated positively with liver, spleen, and bone marrow SUV values and negatively with heterogeneity indices (HI2, HI3). Higher tumor size, HI values, and Bone marrow-to-liver ratio (BLR) SUVmean were associated with increased mortality. A TIL cut-off value of <5 was linked to significantly worse survival.

Conclusion

Our study demonstrates a strong connection between TIL, FDG metabolic parameters, and tumor heterogeneity, particularly in advanced NLBC. Although TIL is not generally associated with SUV values, its association with certain metabolic and heterogeneity indices suggests that it is important in influencing survival. Further research involving larger cohorts and diverse breast cancer subtypes is needed to validate these results.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Fluorodeoxyglucose F18Breast NeoplasmsPositron Emission Tomography Computed TomographyLymphocytes, Tumor-InfiltratingHumansFemaleRetrospective StudiesMiddle AgedAdultRadiopharmaceuticalsAgedPrognosisSurvival RateFollow-Up Studies

Stichwörter der Autor:innen

FDGmetabolic parameternonluminal breast cancertumor heterogeneity indicestumor-infiltrating lymphocytes

Substanzen

Fluorodeoxyglucose F18Radiopharmaceuticals

Autor:innen und Institutionen

  • Department of Nuclear Medicine, Prof. Dr. Cemil Taşcıoğlu City Hospital, University of Health Sciences, Istanbul, Türkiye.
  • Department of Nuclear Medicine, Hamidiye Medical Faculty, University of Health Sciences, Istanbul, Türkiye.
  • Department of Pathology, Prof. Dr. Cemil Taşcıoğlu City Hospital, University of Health Sciences, Istanbul, Türkiye.

Zitieren

APA

Tamam, M., Ozcevik, H., Kulduk, G., Acar Tayyar, M. N., & Babacan, G. B. (2025). Evaluating the correlation between pretreatment 18F-FDG PET/CT metabolic parameters and tumor-infiltrating lymphocyte levels in nonluminal breast cancer and impact on survival. Pathology and Oncology Research, 30. https://doi.org/10.3389/pore.2024.1612014

Vancouver

Tamam M, Ozcevik H, Kulduk G, Acar Tayyar MN, Babacan GB. Evaluating the correlation between pretreatment 18F-FDG PET/CT metabolic parameters and tumor-infiltrating lymphocyte levels in nonluminal breast cancer and impact on survival. Pathology and Oncology Research. 2025;30. doi:10.3389/pore.2024.1612014

BibTeX
@article{Tamam2025,
  author = {Tamam, Muge and Ozcevik, Halim and Kulduk, Gamze and Acar Tayyar, Merve Nur and Babacan, Gunduzalp Bugrahan},
  title = {Evaluating the correlation between pretreatment 18F-FDG PET/CT metabolic parameters and tumor-infiltrating lymphocyte levels in nonluminal breast cancer and impact on survival},
  journal = {Pathology and Oncology Research},
  year = {2025},
  volume = {30},
  doi = {10.3389/pore.2024.1612014}
}
Kostenlos starten →